20/20 GeneSystems, Inc. is one of the fastest-growing privately-owned companies in the nation. Steadfastly committed since its inception to developing a leading position in the cancer screening market, 20/20 successfully leveraged its clinical laboratory operational skills and technical expertise to expand its viral testing services to meet the needs of the community during the COVID-19 pandemic.

20/20 Gene System’s Inc., was selected as the Number 131 company out of INC’s 5000 list, the most prestigious ranking of the United States’ fastest-growing private companies. This distinction is the direct result of creative leadership and commitment of the company’s employees to adapt and take advantage of new opportunities in dedicated to helping innovative challenging times – while still growing the core business model.

​